International Cannabis Weekly: 459

BIPARTISAN BILL SEEKS TO OVERTURN INTOXICATING HEMP BAN AND REGULATE MUTLI-BILLION DOLLAR SECTOR

The US intoxicating hemp market, thought to be worth around $28bn in annual sales, could yet be saved from a devastating ban set to be implemented in a matter of months.

READ MORE  »

DEA RESCHEDULING HEARING CLOSES AS WITNESS CLAIMS CRIME IS REDUCED

READ MORE »

CANNABIS USE AMONG TEENS FLAT AFTER GERMAN PARTIAL LEGALISATION, BUT MEDICAL MARKET CONTINUES RAPID EXPANSION

READ MORE »

• Ananda Pharma doses first patient in NIHR-backed clinical trial targeting chemotherapy-induced nerve pain.
• Rua Bioscience secures its largest-ever export agreement with an unnamed UK medical cannabis clinic.
• Medical cannabis patients should come first as lessons from police training reshape clinical perspectives.
• Hesse approves 21 cannabis cultivation associations with 15 alreadyactively growing cannabis.
• UK NHS trust approves the country’s first inpatient medical cannabis prescribing policy.
• Proposed European carbon market reforms could strengthen the business case for hemp from 2030 onwards.
• Organigram doubles down on Germany after integrating Sanity into its broader European expansion strategy.
• Vienna multiple sclerosis patient launches legal fight for the right to grow medical cannabis at home. 

LEARN MORE »

• Nebraska officials continue work on implementing voter-approved medical cannabis laws amid political debate.
• Oregon modernises cannabis and liquor licensing by launching a new fully digital application system.
• California cannabis industry takes centre stage with a dedicated exhibit at the State Fair.
• Kentucky lawmakers consider allowing medical cannabis access for patients receiving end-of-life care.
• Trulieve expands its Florida footprint by opening a new medical cannabis dispensary in Marco Island.
• Massachusetts officials reject challenge to anti-cannabis initiative signatures clearing measure for November ballot.
• Alabama officials schedule hearing on rescheduling cannabis in line with proposed federal reforms.
• NFL-funded study urges sports leagues to reduce cannabis stigma through better education for athletes.

• SNDL continues integrating Valens while strengthening its cannabis growth strategy across key markets.
• Avicanna launches Quix rapid-onset medical cannabis portfolio to expand patient treatment options.
• Canadian cannabis industry experts question whether consumer packaged goods strategies truly fit the sector.
• Green Thumb Industries expands cannabis retail footprint while revenue grows despite continuing net losses.
• Canopy Growth announces participation in upcoming investor conferences to engage with the financial community.
• Victoria Cannabis Buyers Club wins six-month injunction delaying its planned eviction from current premises.
• Oak Bay council approves rezoning application for a new cannabis retail store on Cadboro Bay Road.

• Mendoza introduces new regulations governing cannabis and hemp research with stricter oversight requirements.
• Mothers caring for children with epilepsy demand access to cannabis-based medicines in Mexico.
• Brazil’s Anvisa publishes scientific contributions to support regulation of medical cannabis cultivation.

• Cronos Australia faces growing pressure as export markets become the industry’s next major challenge.
• Australian cannabis companies face mounting challenges as ambitious export growth strategies are put to the test.
• Leading advertising expert joins ACannabis conference to discuss the industry’s ongoing reputation challenges.
• New Zealand Medicinal Cannabis Council appoints a new executive director following Sally King’s departure.

• Botswana moves ahead with commercial hemp cultivation as the country develops a new agricultural industry.